Genome Canada

Genomic Applications Partnership Program (GAPP)

Amount:

$2,000,000

Type of Program:

Grants

Description:

The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations, and are co-funded by Genome Canada, Receptors and other stakeholders.

Comments on Funding:

Funding is up to 1/3 of the project budget from Genome Canada, from a minimum contribution of $100,000 to a maximum of $2 million.
The remaining project funding must be secured from other eligible sources, with at least 1/3 provided by the Receptor(s).

When It Ends:

Ongoing

Deadline:

Rolling deadline

Eligibility:

Eligible projects must:

be co-led by an eligible Academic researcher and a a senior representative of a Receptor organization in partnership, with active and necessary roles for both,
develop and apply a genomics-derived tool, product or process to an opportunity or need defined by the Receptor(s);
focus on late stage R&D that will position the innovation for near term implementation / commercialization;
have the potential to generate significant social and/or economic benefits for Canada.

The applicant is an academic researcher and he must be:

a faculty member of a Canadian university or affiliated, non-commercial entity, such as hospitals and research institutes,
researchers in not-for-profit corporations or registered charities, if their organization has an explicit research mandate.

The Receptors must:

be organizations that intend to put the resulting innovation into practice (in internal operations, by commercialization, or otherwise making it available to its ultimate users),
be companies (private / public, Canadian / foreign-owned, including small or start up companies),
be industry consortia,
be government departments and agencies (federal, provincial and municipal),
be healthcare organizations,
be not-for-profit organizations,
have clear decision-making processes independent of the Academic Leader.

Application Steps:

Applicants must submit their GAPP applications and the supporting documents via a regional Genome Centre.
They must contact their regional Genome Centre for more information.

Documentation Needed:

Applicants must:

submit an Expression of Interest (EOI) which includes a summary of the proposed project and its value proposition,
“pitch” their project via teleconference to a panel of external industry and technical experts convened by Genome Canada, if invited to,
submit the Supplementary Proposal which provides a more thorough description of several sections of the EOI, including a detailed explanation of the technical aspects, project plan and budget, if invited.

Other Things to Note:

Genome Canada is again welcoming Expressions of Interest for the GAPP. Please contact your Regional Genome Centre for more information on the application process and timelines (June 2021).

Program Contact:

Genomic Applications Partnership Program

gc-gappinvestmentstrategyandguidelines.pdf

Precision Health Initiative – Rare Diseases: Clinical Implementation Projects

Amount:

$ 2,000,000

Type of Program:

Grants

Description:

Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. This project aims to translate research into clinical implementation with the goal of having genome sequencing offered as a clinical genetic test within an established diagnostic and clinical care pathway for rare diseases.

Comments on Funding:

When It Ends:

Ongoing

Deadline:

Rolling deadline

Eligibility:

Eligible projects must:

be co-led by an eligible Academic researcher and a a senior representative of a Receptor organization in partnership, with active and necessary roles for both,
develop and apply a genomics-derived tool, product or process to an opportunity or need defined by the Receptor(s);
focus on late stage R&D that will position the innovation for near term implementation / commercialization;
have the potential to generate significant social and/or economic benefits for Canada,
focus on using precision health approaches in rare diseases that are ready to be implemented in partnership with an existing publicly funded health care delivery organization (at the provincial or regional level that has the technological and organizational infrastructure needed to support the project). The organization should have the capabilities to implement clinical and laboratory workflows; install or upgrade local informatics systems linked to a central data repository; and, validate/benchmark technology platforms.

The applicant is an academic researcher and he must be:

be a faculty member of a Canadian university or affiliated, non-commercial entity, such as hospitals and research institutes,
be a researcher in a not-for-profit corporation, including community or charitable organizations, if his organization has an explicit research mandate,
analyze province specific health technology assessment data to determine the clinical utility, cost utility and cost effectiveness of genomic sequencing,
commit to working with other rare disease clinical implementation projects funded through this mechanism to share best practices and harmonize data capture,
commit to data sharing, data standards, consents and other policies that comply with the guidelines for the overall initiative and are consistent with the principles and policies of the Global Alliance for Genomics and Health, the nternational Rare Diseases International Research Consortium and the FAIR Guiding Principles for scientific data management and stewardship.

The Receptors must:

be organizations that intend to put the resulting innovation into practice (in internal operations, by commercialization, or otherwise making it available to its ultimate users),
be companies (private / public, Canadian / foreign-owned, including small or start up companies),
be industry consortia,
be government departments and agencies (federal, provincial and municipal),
be healthcare organizations,
be not-for-profit organizations,
have clear decision-making processes independent of the Academic Leader.

Application Steps:

Applicants must submit their GAPP applications and the supporting documents via a regional Genome Centre.
They must contact their regional Genome Centre for more information.

Documentation Needed:

Applicants must:

submit an Expression of Interest (EOI) which includes a summary of the proposed project and its value proposition,
“pitch” their project via teleconference to a panel of external industry and technical experts convened by Genome Canada, if invited to,
submit the Supplementary Proposal which provides a more thorough description of several sections of the EOI, including a detailed explanation of the technical aspects, project plan and budget, if invited.

Other Things to Note:

Genome Canada is again welcoming Expressions of Interest for the GAPP. Please contact your Regional Genome Centre for more information on the application process and timelines (June, 2021).

Program Contact:

Precision Health Initiative – Rare Diseases: Clinical Implementation Projects

gc-gappinvestmentstrategyandguidelines.pdf

Genomics in Society Interdisciplinary Research Teams

This program is currently closed.

Amount:

$ 3.000.000

Type of Program:

Grants

Description:

The Genomics in Society Interdisciplinary Research Teams Program aims to strengthen the connections between researchers, users and other stakeholders on issues that could impact the uptake and application of genomic technologies, including commercialization.

There are three funding streams with the goal of funding at least one team in each stream:
Stream 1: proposals mainly impacting the human health sector,
Stream 2: proposals mainly impacting the agriculture/agri-food and/or aquaculture/fisheries sectors,
Stream 3: proposals mainly impacting the natural resource (forestry, energy, mining) and/or environment sectors.

Cross-sectorial proposals that address multiple sectors across two or three streams are also eligible to apply.

Comments on Funding:

Funding is up to 50% of the requested funds for eligible costs, ranging from $500,000 to a maximum of $1 million to an approved team for a term of up to four years.

At least 50% of the requested funds for eligible costs for each team must be obtained through co-funding. At least 50% of the co-funding needs to be secured at the time of the release of funds and a feasible plan needs to be submitted describing how the remaining co-funding will be obtained over the term of the team.

When It Ends:

Closed

Deadline:

May 30, 2019

Eligibility:

Eligible projects must address the following:

The main focus of the team must be to take an interdisciplinary approach to address topics related to the implications of genomics in society (GE3LS research) that will have an impact nationally.
Teams must include at least three researchers from different disciplines at the Leader or Co-Investigator level.
Teams must demonstrate engagement and integration of appropriate genomic scientists and users. Teams that bring together researchers and users from different regions of the country could have a bigger impact nationally; while this approach is encouraged it is not a requirement.
Incorporation of new researchers into the team is encouraged. New researchers include those that are new to genomics and society as well as early stage investigators (defined as being within five years of their first appointment).
All projects must clearly demonstrate engagement with users in the development and execution of the research plan in order to help ensure receptor uptake and practical applicability of the research.
Deliverables should have practical applicability in as short a time as possible after the end of the funding period and lead to significant social and/or economic benefits for Canada.

Applicants must:

be individuals autonomous regarding their research activities,
have an academic or research appointment, being allowed to pursue the proposed research project independently for the duration of the funding, to supervise trainees, and to publish the research results; and being obliged to conform to institutional/organizational regulations and guidelines concerning the conduct of research, the supervision of trainees, and the employment conditions of staff.
be affiliated with a Canadian university or affiliated, non-commercial entity, such as hospitals and research institutes,
be affiliated with a not-for-profit corporation, including community or charitable organizations, if the organization has an explicit research mandate,
be affiliated with Canadian non-federal government departments or agencies.

The users:

are those able to use the information generated through research to make informed decisions on relevant issues, policies, programs and product development,
can be industry and industry associations, producer organizations, government departments and regulatory agencies,
must be clearly integrated into the team in the form of a team member, collaborator and/or member of the management team,
are encouraged to actively collaborate in the priority setting and conduct of research as well as in summarizing, distributing, sharing, and applying its resulting knowledge.

Application Steps:

complete the two steps of the application process: Registration (some basic information to allow for screening for eligibility by the Genome Centres) and Full Application.

apply for funding through their regional Genome Centre.

Documentation Needed:

Applicants must complete and submit:

the Registration form which provides some basic information (who is applying, what they are planning to do, research and expected deliverables, approximate budgets and suggested reviewers) to allow for screening for eligibility by the Genome Centres and facilitate the early selection of reviewers for the peer review process,
the Full Application including more details about the research, its management and finance, the benefits for Canada and a strong plan for knowledge translation and development of benefits (i.e., how the deliverables from the research will be transferred, disseminated, used, and/or applied to realize the social and/or economic benefits).

Other Things to Note:

This competition is now closed.

Program Contact:

Genomics in Society Interdisciplinary Research Teams

guidelinesforfunding.pdf